CelLBxHealth plc ANPCF
Set alert
0.01 USD 0.00 0.00%
At close · Oct 29
0.0098 Day range 0.0098
0.0098 52-week range 0.025
- YTD
- -41.67%
- 1 year
- -60.80%
- Open
- 0.0098
- Prev close
- 0.0098
- Mkt cap
- 11.14M
- Vol
- 10.00K
- Avg vol
- 156
- EPS
- -0.05
- P/E
- 0.00
More statistics
- Low
- 0.0098
- High
- 0.0098
2Y chart
Signals (18)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Jun 11, 2026 | 4 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| RSI: Overbought | May 21, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 24, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 9, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 20, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 18, 2026 | 8 months ago |
| MACD: Buy Signal | Oct 28, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 17, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 18, 2025 | 1 year ago |
News
- CelLBxHealth looking up as it bolsters commercial pipeline
- CelLBxHealth lands contract with Swiss biotech for clinical study
- Cellbxhealth signs new statement of work with US pharma company
- CelLBxHealth's blood test spots hard-to-detect cells from brain tumours
- CelLBxHealth study detects drug targets on cancer cells rivals would miss
- CelLBxHealth moves from cutting to converting
- CelLBxHealth builds £3.5m weighted pipeline as revenue growth target held
- CelLBxHealth reaffirms revenue guidance
- Cavendish backs CelLBxHealth turnaround with buy rating, 4p target
- CelLBxHealth guides for 50% revenue growth as partnership pipeline swells
Your note
Sign in to keep a note on ANPCF — it syncs with the Stock Master app.